Heidemarie Rohrig

Title: Heidemarie Rohrig: Innovator in Progesterone Synthesis Inhibitors

Introduction

Heidemarie Rohrig is a notable inventor based in Jena, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that impact progesterone synthesis.

Latest Patents

Heidemarie Rohrig holds 2 patents related to her innovative work. Her latest patents include the invention of 11 Beta-aryl-gona-4,9-dien-3-ones. This invention pertains to 11.beta.-aryl-gona-4,9-dienes of a specific formula, wherein the variables are defined in the specification. The compounds developed are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, as well as for treating endometriosis, dysmenorrhea, and endocrine hormone-dependent tumors. Another patent also focuses on 11.beta.-aryl-gona-4,9-dien-3-ones, which are progesterone antagonists and are similarly suitable for inducing labor or an abortion.

Career Highlights

Heidemarie Rohrig is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. Her work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Heidemarie has collaborated with notable colleagues, including Helmut Kasch and Gudrun Bertram, who have contributed to her research endeavors.

Conclusion

Heidemarie Rohrig's innovative work in the field of progesterone synthesis inhibitors showcases her dedication to advancing medical science. Her contributions have the potential to significantly impact women's health and reproductive medicine.